Sector: Pharmaceuticals & Biotechnology

Small Cap

Welcure Drugs Share Price

Q: What is the Market Capitalization of Welcure Drugs & Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Welcure Drugs & Pharmaceuticals Ltd. is approximately ₹ 32.1 Cr.

Q: What are the PE and PB ratios for Welcure Drugs & Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Welcure Drugs & Pharmaceuticals Ltd. is -1.9, and the Price-to-Book (PB) ratio is 0.3.

Q: What is the 52-Week High and Low for Welcure Drugs & Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Welcure Drugs & Pharmaceuticals Ltd. shares was ₹ 1.24, and the lowest price was ₹ 0.23.

Q: Who are the major shareholders of Welcure Drugs & Pharmaceuticals Ltd.?

Significant shareholdings in Welcure Drugs & Pharmaceuticals Ltd. typically include entities such as: Public Promoter Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Welcure Drugs & Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Welcure Drugs & Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

WELCURE

₹0.26

0.00(0.00%)

10th Jul 2026 | 3:28 PM

NSE :

Open Free Demat Account

Welcure Drugs Performance

Price Movement

N/A

₹0.25

₹0.27

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹0.27

Low₹0.25

Open at₹0.26

Prev Close₹0.26

Volumes49.67 L

Avg Price₹0.25

Lower Circuit₹0.23

Upper Circuit₹0.27

Historical Performance

3M High₹0.36

3M Low₹0.24

1 Yr High₹1.24

1 Yr Low₹0.23

3 Yr High₹1.44

3 Yr Low₹0.23

5 Yr High₹1.44

5 Yr Low₹0.23

Summary

As of 10-07-2026 21:39, Welcure Drugs & Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-0.26 (-100.00%) from the previous close of ₹0.26. The stock opened at ₹0.26 and traded between ₹0.25 and ₹0.27, with a total traded volume of 4967017 shares. The company has a market capitalization of ₹32.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1.24 and ₹0.23, respectively.

Welcure Drugs & Pharmaceuticals Ltd. valuation metrics include a P/E ratio of -1.9, and book value of ₹0.30. Profitability indicators show ROE of -5.65%. Welcure Drugs & Pharmaceuticals Ltd. has reported revenue of ₹365.54 Cr and net profit of ₹-16.99 Cr.

Welcure Drugs & Pharmaceuticals Ltd. technical indicators include Day RSI at 46.49, Day MFI at 27.42, Day ADX at 15.5. Additional indicators include Commodity Channel Index (CCI) at -104.6 and Williams %R at -50. Momentum indicators show DayATR at 0.02. Rate of Change indicators for Welcure Drugs & Pharmaceuticals Ltd. include ROC125 at -40.91 and ROC21 at -3.7.

Exponential moving averages include EMA5 at ₹0.3, EMA10 at ₹0.3, EMA12 at ₹0.3, EMA20 at ₹0.3, EMA26 at ₹0.3, EMA50 at ₹0.3, EMA100 at ₹0.3, EMA200 at ₹0.4. Simple moving averages include SMA5 at ₹0.3, SMA10 at ₹0.3, SMA20 at ₹0.3, SMA30 at ₹0.3, SMA50 at ₹0.3, SMA100 at ₹0.3, SMA150 at ₹0.3, SMA200 at ₹0.4.

Support levels for Welcure Drugs are placed at First Support ₹0.25, Second Support ₹0.23, Third Support ₹0.23. Resistance levels are seen at First Resistance ₹0.27, Second Resistance ₹0.27, Third Resistance ₹0.29. Welcure Drugs & Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 0%, FII holding at 0%, DII holding at 0%, public holding at 100%.

Welcure Drugs Fundamentals

Market Cap

Low in industry

32.10 Cr.

PE Ratio (TTM)

Negative PE TTM

-1.90

Dividend Yield

Net Profit TTM

482% decr over last year

-16.99

Net Profit Growth

482% decr over last year

-16.99

PEG Ratio

Below industry Median

ROE

368% decr over last year

-5.65

Operating Revenue TTM

365.54

Operating Revenue Growth

569.5% incr over last year

Book Value

Low in industry

0.30

MFI

MFI oversold

27.42

RSI

RSI is mid-range

46.49

EPS (TTM)

-1.46

Debt to Equity

-2.97

Face Value

Operating Profit Margin Qtr.

-119.40

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

0.30

Welcure Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	0	0	65.62	299.91	21.21
Operating Expense	49.86	0.03	54.25	268.77	20.58
Operating Profit	-49.86	-0.03	11.37	31.14	0.64
Depreciation	0	0	0	0	0.01
Interest	0	0	0	0	0
Tax	0	0.36	2.86	7.84	0
Net Profit	-49.86	1.07	8.50	23.30	2.54

Welcure Drugs Technicals

Welcure Drugs & Pharmaceuticals Ltd. EMA & SMA

₹0.26

0.01 (4.00%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹0.3

Day EMA10 ₹0.3

Day EMA12 ₹0.3

Day EMA20 ₹0.3

Day EMA26 ₹0.3

Day EMA50 ₹0.3

Day EMA100 ₹0.3

Day EMA200 ₹0.4

Welcure Drugs Support and Resistance

Resistance

First Resistance₹0.27

Second Resistance₹0.27

Third Resistance₹0.29

Support

First Support₹0.25

Second Support₹0.23

Third Support₹0.23

Technical Indicators

Day RSI46.49

Day MFI27.42

Day ADX15.50

Day Commodity Channel Index-104.60

William-50.00

Day MACD-

Day MACD Signal Line-

Day ATR0.02

Day ROC125-40.91

Day ROC21-3.70

Welcure Drugs Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	0	0	0	0	0	0
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	100	100	100	100	100	100

Welcure Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	28.82 L	45.72 L	63.04%
Week	24.83 L	34.75 L	71.44%
1 Month	26.57 L	51.99 L	51.10%
6 Month	44.19 L	93.06 L	47.49%

Welcure Drugs SWOT Analysis

Strengths10

Weakness12

Opportunity0

Threats0

Companies with no Debt

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Companies with reducing Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Top Gainers

Volume Shockers

Welcure Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Welcure Drugs Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹41	₹587.60	₹183.50	₹259.30	₹35	₹5.40
% Change	0.00%	-1.43%	-0.27%	0.00%	-2.78%	-0.18%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	9.60	-	12.40	37.00	-85.20	-1.30
1 Year Return		52.07			700	441
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 224.00

+1.93%

AMANTA

Amanta Healthcare Ltd.

₹ 179.17

-2.00%

AHCL

Anlon Healthcare Ltd.

₹ 15.60

+0.84%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 95.00

-1.04%

APL

Asston Pharmaceuticals Ltd.

₹ 76.50

+1.32%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 535.00

-0.10%

ASTONEALAB

Astonea Labs Ltd.

₹ 282.55

+1.99%

AMWILL

Amwill Health Care Ltd.

₹ 41.00

-3.91%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 62.00

-0.26%

SHELTER

Shelter Pharma Ltd.

₹ 27.40

+6.41%

TLL

Trident Lifeline Ltd.

₹ 262.50

-0.61%

DPL

Dipna Pharmachem Ltd.

₹ 5.76

-8.86%

ACHYUT

Achyut Healthcare Ltd.

₹ 8.20

+0.12%

SIGACHI

Sigachi Industries Ltd.

₹ 22.67

+1.98%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+0.50%

VINEETLAB

Vineet Laboratories Ltd.

₹ 32.80

+0.43%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 38.55

-4.98%

CHCL

Cian Healthcare Ltd.

₹ 8.67

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 568.90

+0.36%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.41

+0.00%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.62

-1.99%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1402.00

-0.61%

MEDICO

Medico Remedies Ltd.

₹ 39.10

+0.03%

SGRL

Shree Ganesh Remedies Ltd.

₹ 687.00

+1.43%

FAQ's on WELCURE

What is the Market Capitalization of Welcure Drugs & Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Welcure Drugs & Pharmaceuticals Ltd. is approximately ₹ 32.1 Cr.

What are the PE and PB ratios for Welcure Drugs & Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Welcure Drugs & Pharmaceuticals Ltd. is -1.9, and the Price-to-Book (PB) ratio is 0.3.

What is the 52-Week High and Low for Welcure Drugs & Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Welcure Drugs & Pharmaceuticals Ltd. shares was ₹ 1.24, and the lowest price was ₹ 0.23.

Who are the major shareholders of Welcure Drugs & Pharmaceuticals Ltd.?

Significant shareholdings in Welcure Drugs & Pharmaceuticals Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Welcure Drugs & Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Welcure Drugs & Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy